UN agencies denounce the India/EU Free Trade Agreement
On Wednesday, UN UNAIDS agencies, the United Nations Development Program (UNDP) and the World Health Organization (WHO) reported their deep concern over the increasing number of agreements going beyond the scope of TRIPS Agreement, that is to say increasing the duration of patents and monopolies of drug companies on vital medicines. These agreements have dramatic consequences on access to health products for people living with HIV in poor countries. Studies have shown that the cost of health spending has drastically risen in developing countries that have signed such agreements in the past. Ten days ago, UNITAID [[See UNITAID press release: http://www.unitaid.eu/en/resources/]] - the international facility for drugs purchasing – also denounced these agreements.
